Michael Knauer

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 565 citations

Medicine, Oncology, Surgery +17

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

Michael Gnant, Martin Filipits, Richard Greil et al. · Annals of Oncology · 2013 · 399 citations · Full text

Medicine, Oncology, Breast Oncology +13

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

Michael Gnant, Brigitte Mlineritsch, Herbert Stoeger et al. · Annals of Oncology · 2014 · 307 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Axillary Surgery in Breast Cancer — Primary Results of the INSEMA Trial

Toralf Reimer, Angrit Stachs, Kristina Veselinovic et al. · New England Journal of Medicine · 2024 · 248 citations

Medicine, Oncology, Surgery +16

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study

Caroline A. Drukker, J.M. Bueno-De-Mesquita, Valesca P. Retèl et al. · International Journal of Cancer · 2013 · 225 citations · Full text

Medicine, Biostatistics, Oncology +17